Cris De Luca
Partner at Sanofi Ventures
Cambridge, Massachusetts
Overview
Work Experience
Partner, Digital and AI Investments at Sanofi Ventures
2020 - Current
Partner at Sanofi Ventures leading venture capital investments in Digital Health, AI, & Data Science Innovation, globally. We invest in top-tier biotech and digital health/AI companies that focus on helping patients and transforming the practice of medicine. We invest across all stages of the private company lifecycle, from Seed to Series B and beyond, while leading financings, serving on boards, and taking pride in working alongside portfolio companies to drive long-term value. Learn more at www.sanofiventures.com
Board Member
2023
Carbon Health is a tech-enabled healthcare company that delivers a virtual care experience.
Raised $622,500,000.00 from BAM Elevate, The K Fund, WP Global Partners, CVS Health Ventures, Nolan Arenado, Sand Hill Angels, Karim Temsamani and Red Hook Capital.
Board Member
2022
Empatica is an affective computing company focused on human data analytics.
Raised $33,729,980.00 from RA Capital Management, Sanofi Ventures and Black Opal Ventures.
Board Member
2022
Board Member
2021
Medisafe is a personalized tech platform that helps people manage their medications while providing insight into their daily habits.
Raised $51,500,000.00 from Octopus Ventures, lool ventures, Sanofi Ventures, Triventures, 7wire Ventures, OurCrowd, Leumi Partners, Consensus Business Group, ALIVE Israel HealthTech Fund and Pitango VC.
Board Member
2020
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Raised $957,652,435.00 from HSBC Innovation Banking and Silicon Valley Bank.
Board Observer
2021
Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.
Raised $528,520,000.00 from Trousdale Ventures, Wellington Management, Empede Capital, aMoon Fund, Civilization Ventures, Fidelity, Perceptive Advisors and Revelation Partners.
Board Observer
2020
Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
Raised $203,600,000.00 from B Capital, Warburg Pincus, Foresite Capital, Flare Capital Partners and New Enterprise Associates.
Board Observer
2020 - 2021
Common Sensing develops and manufactures data-driven hardware and software solutions for people using injectable medicine.
Raised $13,883,285.00 from Pleasant Bay Capital Partners.
Investor
2020 - 2021
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Raised $347,500,000.00 from Lux Capital, RTW Investments, Mubadala Capital Ventures, Pura Vida Investments, Casdin Capital, BlackRock, LifeSci Venture Partners, Redmile Group, PPD clinical research business of Thermo Fisher Scientific and Samsara BioCapital.